Hospices Civils de Lyon

Pierre-Bénite 69495

1 studies enrolling now · 7 studies all time

What they study most

Advanced Cutaneous Squamous Cell Carcinoma, Breast Cancer, Cutaneous Squamous Cell Carcinoma, HER2 Positive Breast Cancer, Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV, Metastatic Breast Cancer, Metastatic Cutaneous Squamous Cell Carcinoma, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Short Bowel Syndrome

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now
• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer — Running, not enrolling
• Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF — Completed
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer — Completed
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer — Completed